All Episodes

21 Atorvastatin (S24E21)

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The ALCOA+ Standard (S25E5)

20 Liraglutide (S24E20)

18 Pioglitazone (S24E18)

17 Sitagliptin (S24E17)

19 Exenatide (S24E19)

16 Glipizide (S24E16)

184 - Episode 4 - Quality System Regulation (QSR): The Backbone of Medical Device Manufacturing (21 CFR Part 820) (S25E4)

183 - Episode 3 - Device Classification and Premarket Pathways - Navigating FDA Clearance (S25E3)

182 - Episode 2 - The Medical Device Development Lifecycle: From Concept to Commercialization (S25E2)

15 Insulin (S24E15)

14 Metformin (S24E14)

13 Clindamycin (S24E13)

12 Levofloxacin (S24E12)

11 Ciprofloxacin (S24E11)

181 - Episode 1 - Introduction to Medical Devices and Their Regulatory Landscape (S25E1)

Azithromycin (S24E10)

Erythromycin (S24E9)

Amoxicillin (S24E8)

Penicillin (S24E7)

Celecoxib (Celebrex) (S24E6)

Diclofenac (S24E5)

Naproxen (S24E4)

Ibuprofen (S24E3)

Acetaminophen (S24E2)

Aspirin (S24E1)

63 - Audit Readiness and Continuous Improvement in Clinical Quality Systems (S23E4)

62 - Documentation, Informed Consent, and Safety Reporting (S23E3)

61 - Operational Excellence in Clinical Trials Monitoring & Data Management (S23E2)

60 – cGCP Fundamentals and Regulatory Overview (S23E1)

59- Data Integrity, Informed Consent, and Recordkeeping in cGCP (S22E5)

57 - Protocol Design, Investigator Responsibilities, and Documentation (S22E3)

58 - Risk Management and Quality Assurance in Clinical Trials (S22E4)

56 - The Historical Evolution of cGCPs (S22E2)

55 - What are cGCPs? Foundations and Ethical Principles (S22E1)

54- Compliance, Enforcement, and Audit Mechanisms (S21E5)

53 – ICH Guidelines and Global Harmonization (S21E4)

52 - European and International Regulatory Perspectives (S21E3)

51 – In-Depth Analysis of FDA cGCP Regulations (S21E2)

50 – Overview of the cGCP Regulatory Landscape (S21E1)

180 - Season 12 Recap & Closing the Journey (S12E15)

179 - Preparing for the Unknown (S12E14)

178 - Future Manufacturing Technologies (S12E13)

177 - Policy Changes Shaping the Future (S12E12)

176 - Next-Gen Clinical Trial Designs (S12E11)

175 - Balancing Innovation and Safety (S12E10)

174 - Global Collaboration & Open Innovation (S12E9)

173 - The Evolving Role of Al in R&D (S12E8)

172 - Sustainability & Green Chemistry in Pharma (S12E7)

170 - Emerging Trends in Personalized Development (S12E5)

171 - Patient Data & Digital Health Records (S12E6)

169 - Regulatory Science of the Future (S12E4)

168 - Advances in Biotechnology & Gene Therapy (S12E3)

167 - Precision Medicine & Genomic Innovations (S12E2)

166 - Future of Drug Discovery (S12E1)

64 - FDA 2025 Inspection Operations Manual - What to Expect When You’re Expecting… an FDA Inspection (S19E8)

49 – Audit Readiness and Advanced Topics (S20E4)

48 - Documentation, Lab Practices & Quality Systems (S20E3)

47 - Operational Excellence Validation, Equipment & Processes (S20E2)

46 – cGMP Fundamentals and Regulatory Overview (S20E1)

45 - Current Trends and Future Directions in GMP (S19E7)

44 - Preparing for Regulatory Inspections (S19E6)

43 - Case Study 2 Example of Successful GMP Implementation (S19E5)

42 - Case Study 1 Illustrative GMP Failure (S19E4)

41 - Complaint Handling and Product Recalls Protecting Patients (S19E3)

40 - Handling Deviations and Non-Conformances (S19E2)

39 - Stability Programs and Shelf Life Determination (S19E1)

38 – FDA Form 483 Implications and Impact (S18E6)

37 – Establishing and Maintaining a GMP Quality Management System (QMS) (S18E5)

36 – Audit Findings and Corrective and Preventive Actions (CAPA) (S18E4)

35 – Conducting the GMP Audit Best Practices (S18E3)

34 - Planning and Preparing for a GMP Audit (S18E2)

33 – The Role of GMP Audits in Ensuring Compliance (S18E1)

165 - From Lab Bench to Pilot Plant: Navigating the Challenges of Chemical Process Scale-Up (S11E15)

164 - Strategic Approaches to Impurity Control in Multi-Step Organic Syntheses (S11E14)

163 - Implementing Continuous Flow Reactors for Enhanced Process Safety and Efficiency (S11E13)

162 - The Art and Science of Crystallization in Pharmaceutical Development (S11E12)

161 - Optimizing Reaction Conditions Through Design of Experiments (DoE) (S11E11)

160 - Addressing Impurities and By-Products in Pharmaceutical Process Development (S11E10)

159 - Innovations in Crystallization Techniques for Active Pharmaceutical Ingredients (S11E9)

158 - Special Feature Sections in Organic Process Research & Development: Hot Topics (S11E8)

157 - The Role of Quality by Design (QbD) in Pharmaceutical Development and Manufacturing (S11E7)

156 - Overcoming Scale-Up Challenges in Pharmaceutical Process Development (S11E6)

155 - Applications of Flow Chemistry in Modern Drug Development (S11E5)

154 - Regulatory Considerations for Starting Materials in Drug Substance Development (S11E4)

153 - The Evolving Landscape of Continuous Processing in Pharmaceutical Manufacturing (S11E3)

152 - Challenges and Strategies in Peptide Drug Synthesis and Manufacturing (S11E2)

151 - Rapid Process Development and Scale-Up Using Multiple Reactors (S11E1)

21 - Principles of Good Documentation Practices (GDP) (S16E1)

32 - Data Management, Records, and Reporting in GLP (S17E6)

31 - GLP Protocols and Standard Operating Procedures (S17E5)

30 - Test Systems and Test and Reference Items in GLP (S17E4)

28 – Key Elements of GLP Organization and Personnel (S17E2)

29 – GLP Requirements for Facilities and Equipment (S17E3)

27 - Introduction to Good Laboratory Practices (GLP) (S17E1)

26 – Electronic Records and Signatures Navigating 21 CFR Part 11 (S16E6)

24 - Batch Records The History of a Batch (S16E4)

25 - Laboratory Notebooks and Data Recording (S16E5)

23 - Standard Operating Procedures (SOPs) Your GMP Blueprints (S16E3)

22 – The ALCOA+ Principles Ensuring Data Integrity (S16E2)

150 – Season 10 Recap & Vision Forward (S10E15)

149 – Future Trends in Digital Pharma (S10E14)

148 – Regulatory Considerations for Digital Health (S10E13)

147 – Telemedicine & Decentralized Trials (S10E12)

146 – Wearable Technology & Patient Monitoring (S10E11)

145 – Case Study: Digital Innovation Accelerating R&D (S10E10)

144 – Big Data & Real-World Evidence (S10E9)

143 – Cloud Computing & Data Security (S10E8)

142 – IoT & Smart Manufacturing (S10E7)

141 - Real-Time Data Analytics in Clinical Trials (S10E6)

140 – Digital Twins in Process Development (S10E5)

139 - Blockchain for Supply Chain Transparency (S10E4)

138 - Virtual & Augmented Reality in Pharma (S10E3)

137 – AI & Machine Learning in Drug Discovery (S10E2)

136 - Digital Transformation in Pharma (S10E1)

20 - Quality Risk Management: A Proactive Approach (S15E6)

19 - Materials Management: From Raw Materials to Finished Products (S15E5)

18 - Change Control: Managing Modifications Effectively (S15E4)

17 - Equipment Qualification: IQ, OQ, PQ (S15E3)

16 - Cleaning Validation: Preventing Cross-Contamination (S15E2)

15 - Process Validation: Ensuring Consistent Quality (S15E1)

14 – FDA 21 CFR Part 211 Returned and Salvaged Drug Products (S14E11)

13 – FDA 21 CFR Part 211 Records and Reports (S14E10)

12 – FDA 21 CFR Part 211 Laboratory Controls (S14E9)

11 – FDA 21 CFR Part 211 Holding and Distribution (S14E8)

10 – FDA 21 CFR Part 211 Packaging and Labeling Control (S14E7)

9 – FDA 21 CFR Part 211 Production and Process Controls (S14E6)

8 – FDA 21 CFR Part 211 Control of Components and Drug Containers (S14E5)

7 – FDA 21 CFR Part 211 Equipment (S14E4)

6 – FDA 21 CFR Part 211 Buildings and Facilities (S14E3)

5 - FDA 21 CFR Part 211 Organization and Personnel (S14E2)

4 - Understanding FDA 21 CFR Part 210 (S14E1)

3 - Global Regulatory Frameworks and cGMP (S13E3)

2 - The Historical Evolution of GMP (S13E2)

1 - What are cGMPs? (S13E1)

134 – Integrating AI in Quality Control (S9E14)

135 – Season 9 Recap & Reflections (S9E15)

133 – Emerging Technologies in Analytical Testing (S9E13)

132 – Quality Control in Continuous Manufacturing (S9E12)

131 - Validation of Analytical Methods (S9E11)

130 - Automation in Analytical Labs (S9E10)

129 - Case Study: Tackling Complex Impurities (S9E9)

128 - Data Integrity in QC (S9E8)

127 - Process Analytical Technology (PAT) (S9E7)

126 - Stability Testing & Forced Degradation (S9E6)

125 - Dissolution Testing & Bioequivalence (S9E5)

124 - Spectroscopy & Quality Control (S9E4)

123 - Mass Spectrometry in Drug Analysis (S9E3)

122 - Innovations in Chromatography (S9E2)

121 – Advanced Analytical Techniques Overview (S9E1)

120 – Season 8 Recap & Future Outlook (S8E15)

119 – Emerging Trends in Regulatory Science (S8E14)

118 – Digital Tools in Surveillance (S8E13)

116 – Real-World Evidence Impact (S8E11)

117 – Patient Registries & Long-Term Studies (S8E12)

115 – Labeling Changes & Post-Market Commitments (S8E10)

114 – Case Study: Navigating a Regulatory Challenge (S8E9)

113 – Regulatory Inspections & Audits (S8E8)

112 – Global Regulatory Variations (S8E7)

111 – REMS and Risk Mitigation Strategies (S8E6)

110 – Adverse Event Reporting Explained (S8E5)

109 – Post-Marketing Surveillance (S8E4)

108 – Role of Pharmacovigilance (S8E3)

107 – FDA & ICH Guidelines Overview (S8E2)

106 – Deep Dive into Regulatory Affairs (S8E1)

105 – Season 7 Recap & Future Directions (S7E15)

104 – Advanced Drug Delivery Systems (S7E14)

103 - Patient-Centric Design in Drug Delivery (S7E13)

101 - Packaging, Storage, and Cold Chain (S7E11)

102 - Regulatory Aspects of Formulation (S7E12)

100 – Case Study: Formulation to Market Success (S7E10)

99 - Analytical Methods in Formulation Testing (S7E9)

97 - Stability Indicating Methods & Shelf-life (S7E7)

98 - Quality by Design in Formulation (S7E8)

96 - Controlled Release & Targeted Delivery (S7E6)

95 – Overview of Drug Delivery Technologies (S7E5)

94 - Formulation Challenges for Biologics & Injectables (S7E4)

93 – Oral Dosage Formulation Strategies (S7E3)

92 - Excipients: Roles and Selection (S7E2)

91 - Fundamentals of Formulation Development (S7E1)

90 – Season 6 Recap & Integration (S6E15)

89 – Environmental & Safety Considerations (S6E14)

88 – Risk Management in Process Scale-Up (S6E13)

87 – Continuous Manufacturing & Emerging Trends (S6E12)

86 - Technology Transfer from Lab to Plant (S6E11)

84 – Case Study: Manufacturing a Complex Molecule (S6E9)

85 – Process Validation & Regulatory Requirements (S6E10)

83 – Analytical Methods in Process Development (S6E8)

81 – Crystallization and Solid Form Selection (S6E6)

82 – Impurity Profiling & Control Strategies (S6E7)

80 – Purification & Isolation Techniques (S6E5)

79 – Reactor Design & Scale-Up Challenges (S6E4)

78 – Process Optimization & QbD Principles (S6E3)

77 – Process Chemistry: From Bench to Plant (S6E2)

76 – Introduction to Drug Manufacturing & Scale-Up (S6E1)

75 – Season 5 Recap & Lessons Learned (S5E15)

74 - Global Regulatory Harmonization (S5E14)

73 - Handling Regulatory Feedback & Resubmissions (S5E13)

71 - Accelerated Approval & Breakthrough Therapies (S5E11)

72 - Post-Approval Commitments and Phase IV (S5E12)

70 - Labeling, Risk Management, and REMS (S5E10)

69 - Advisory Committees & Public Hearings (S5E9)

68 - Regulatory Review: What the FDA Expects (S5E8)

67 – NDA/BLA Submission Process (S5E7)

66 – Phase 3 Success: A Case Study (S5E6)

65 - Managing Adverse Events in Large Trials (S5E5)

64 - Global Clinical Trials & Coordination (S5E4)

63 - Statistical Considerations in Phase 3 (S5E3)

62 - Designing Robust Phase 3 Studies (S5E2)

61 - Phase 3 - Large-Scale Efficacy Trials Overview (S5E1)

60 - Season 4 Recap & Bridging to Later Phases (S4E15)

59 – Real-World Examples (S4E14)

58 – Communication with Regulators in Early Trials (S4E13)

57 - Data Analysis in Early Trials (S4E12)

56 - Monitoring Safety and Efficacy in Phase 2 (S4E11)

55 - Patient Recruitment & Ethics in Early Trials (S4E10)

54 - Adaptive Designs in Early Trials (S4E9)

53 - Biomarkers in Phase 2 Trials (S4E8)

52 – Phase 2 Trial Design & Endpoints (S4E7)

51 - Transitioning to Phase 2 - Efficacy Focus (S4E6)

50 – Phase 1 Case Study & Lessons Learned (S4E5)

49 – Dose Escalation & Determining MTD (S4E4)

48 – PK/PD in Phase 1 (S4E3)

47 - Designing Phase 1 Safety Trials (S4E2)

46 – Phase 1: First-in-Human Studies Overview (S4E1)

45 - Season 3 Recap & Transition to Clinical Trials (S3E15)

44 - Risk Management in Preclinical Phase (S3E14)

43 - Integrating Preclinical Data for IND (S3E13)

42 - Case Study: Preclinical Success Story (S3E12)

41 - Preclinical Regulatory Interactions (S3E11)

40 – Immunogenicity Assessment in Biologics (S3E10)

39 - Stability Testing in Preclinical Phase (S3E9)

38 - Bioanalytical Method Development (S3E8)

37 - CMC Considerations in Preclinical Stage (S3E7)

36 - IND-Enabling Studies Overview (S3E6)

35 - Preclinical Efficacy Models (S3E5)

34 - Dose Range Finding Studies (S3E4)

33 - Safety Pharmacology & Off-Target Screening (S3E3)

32 - Pharmacokinetics in Preclinical Testing (S3E2)

31 - Preclinical Toxicology Studies (S3E1)

30- Season 2 Recap and Integration (S2E15)

29 - Preclinical Preparation and IND Planning (S2E14)

28 - Selecting a Development Candidate (S2E13)

27 - Early Safety Screening (ADME-Tox) (S2E12)

26 - Challenges in Early Discovery (S2E11)

25- Case Study: A Drug Discovery Success (S2E10)

23 - Drug-like Properties & ADME (S2E8)

24 - Natural Products and Drug Discovery (S2E9)

22 - Medicinal Chemistry 101: SAR (S2E7)

20 - Computational Drug Design & Virtual Screening (S2E5)

21 - Hit-to-Lead and Lead Optimization (S2E6)

19- Fragment-Based Drug Discovery (S2E4)

18 – High-Throughput Screening (S2E3)

17- Target Validation Techniques (S2E2)

16- Selecting the Right Drug Target (S2E1)

15- Season 1 Recap and Future Preview (S1E15)

14-Team Science: Collaboration in R&D (S1E14)

13 - Risk and Failure in Drug Development (S1E13)

12 - Funding and Economics of Drug Development (S1E12)

11- Patents and Intellectual Property (S1E11)

10 - Formulation and Drug Delivery Basics (S1E10)

9 - Basics of Drug Manufacturing (S1E9)

8 - Regulatory Affairs 101 (S1E8)

7- Clinical Trial Phases Overview (S1E7)

6- Preclinical Research Overview (S1E6)

5 – Overview of Drug Discovery Process (S1E5)

4 - Pharmacology Basics: How Drugs Work (S1E4)

3 - From Idea to Target Selection (S1E3)

2- History of Drug Discovery (S1E2)

1 - Introduction to Drug Development (S1E1)